Showing 20 of 81 recruiting trials for “squamous-cell-carcinoma-of-head-and-neck”
A Study of SI-B001+SI-B003 Combined With Platinum-based Chemotherapy as First-line Treatment in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
A Study of DM005 in Patients With Advanced Solid Tumors
A Phase 3 Study of AK112 Plus AK117 Versus Pembrolizumab in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC)
Clinical Trial of SIBP-03 in Patients With Head and Neck Squamous Cell Carcinoma
Neck Observation or Elective Neck Dissection in CT1N0M0 OSCC
2 Courses of Concurrent Cisplatin Chemoradiotherapy After Surgery for High-risk Head and Neck Squamous Cell Carcinoma
A Study of VET3-TGI in Patients With Solid Tumors
SBRT Followed by Chemoimmunotherapy of Toripalimab Plus Docetaxel and Cisplatin for Larynx Preservation in Patients with Locally Regionally Advanced Squamous Cell Carcinoma of the Larynx and Hypopharynx
RecruitingNCT06575322 ↗
Effects of Neoadjuvant Therapy With Carboplatin, Paclitaxel Combined With Anti-PD-1 Drugs on Pain, Anxiety and Depression in Patients With Resectable Head and Neck Squamous Cell Carcinoma
👨⚕️ Song Fan, Doctor, Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University📍 1 site📅 Started Sep 2024View details ↗
RecruitingNCT06755762 ↗
Using a 3D Culture Model for Circulating Tumor Cells Combined With Molecular Bioassays in Patients With HNSCC Cancer
👨⚕️ Chia-Hsun Hsieh, PhD, Division of Oncology, Chang Gung Memorial Hospital📍 1 site📅 Started Aug 2024View details ↗
A Phase I/II Trial of UCB4594 in Participants With Advanced Cancer
👨⚕️ Fiona Thistlethwaite, Prof, The Christie NHS Foundation Trust📍 2 sites📅 Started Jul 2024View details ↗
A Phase II Study of Neoadjuvant Immunotherapy in Combination With Chemotherapy in Locally Advanced Head and Neck Squamous Cell Carcinoma
A Study of BL-B16D1 in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma and Other Solid Tumors
A Study of BL-B01D1+PD-1 Monoclonal Antibody in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma and Other Solid Tumors
European Larynx Organ Preservation Study (ELOS) [MK-3475-C44]
Tislelizumab Combined With Chemotherapy Followed by Surgery Versus Up-front Surgery in Resectable Clinically Node-negative Head and Neck Squamous Cell Carcinoma
A Study of MGC026 in Participants With Advanced Solid Tumors
GB1211 and Pembrolizumab Versus Pembrolizumab and Placebo in Patients With Metastatic Melanoma and Head and Neck Squamous Cell Carcinoma
Methylnatrexone In Resectable Head and Neck Squamous Cell Carcinoma (MINK). A "Window of Opportunity" Pilot Study.
Response Adaptive Radiotherapy Following Immunotherapy-based Induction for Non-HPV Related HNSCC
👨⚕️ Junlin Yi, Doctor, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, CAMS & PUMC📍 1 site📅 Started Jan 2024View details ↗
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →